Andreas Mörner

Primary Human Immunodeficiency Virus Type 2 (HIV-2) Isolates, Like HIV-1 Isolates, Frequently Use CCR5 but Show Promiscuity in Coreceptor Usage

Andreas Mörner, Åsa Björndal, Jan Albert et al. · Journal of Virology · 1999 · 328 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +12

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis

Meliha C Kapetanovic, Lars-Erik Kristensen, Tore Saxne et al. · Arthritis Research & Therapy · 2014 · 79 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

B Cell Recognition of the Conserved HIV-1 Co-Receptor Binding Site Is Altered by Endogenous Primate CD4

Mattias N.E. Forsell, Barna Dey, Andreas Mörner et al. · PLoS Pathogens · 2008 · 63 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen

Barbro Mäkitalo, Peter Lundholm, Jorma Hinkula et al. · Journal of General Virology · 2004 · 63 citations

Life Sciences, Immunology, Infectious Diseases +17

Human Immunodeficiency Virus Type 1 Env Trimer Immunization of Macaques and Impact of Priming with Viral Vector or Stabilized Core Protein

Andreas Mörner, Iyadh Douagi, Mattias N.E. Forsell et al. · Journal of Virology · 2008 · 56 citations

Life Sciences, Immunology, Infectious Diseases +16